Santhera Pharmaceuticals Holding AG (0QN1.L) LSE

10.24

-0.03841(-0.37%)

Updated at November 07 05:15PM

Currency In CHF

Valuation

Market Cap157.2M
Enterprise Value156.9M
P/E Ratio-1.99
PEG Ratio0.04
Price/Sales Ratio2.69
Price/Book Ratio-50.86
Enterprise/Revenue3.87
Enterprise/EBITDA-5.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.34
Operating Margin-1.04

Management Effectiveness

Return On Assets-0.5
Return On Equity-5.22

Income Statement

Revenue39.12M
Revenue/Share3.84
Gross Profit22.96M
EBITDA-15.89M
Net Income-41.97M
Diluted EPS-3.69

Balance Sheet

Total Cash18.4M
Total Cash/Share1.44
Total Debt76.3M
Total Debt/Equity-29.77
Current Ratio1.02
Book Value Per Share-0.2

Price History

52-Week Change18.4
52-Week High13.83
52-Week Low6.15
Moving Average 50 Days9.91
Moving Average 200 Days8.98

Statistics

Average Volume1,302
Shares Outstanding12.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJuly 03, 2023